BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rui Cao, Wenping Song, Cheng Ye, Xiujun Liu, Liang Li, Yi Li, Hongjuan Yao, Xiaofei Zhou, Liang Li, Rongguang Shao. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancerCancer Medicine 2019; 8(2): 643 doi: 10.1002/cam4.1974
2
Shu Ming Chai, Ser Yee Lee. High Endothelial Venules and Pancreatic Ductal Adenocarcinoma: A potential game changerEBioMedicine 2019; 39: 29 doi: 10.1016/j.ebiom.2018.11.061
3
Diane Bressand, Anthony Novell, Alban Girault, William Raoul, Gaëlle Fromont-Hankard, Jean-Michel Escoffre, Thierry Lecomte, Ayache Bouakaz. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer ModelMolecular Pharmaceutics 2019; 16(9): 3814 doi: 10.1021/acs.molpharmaceut.9b00416
4
Masahiro Yasunaga, Shino Manabe, Masaru Furuta, Koretsugu Ogata, Yoshikatsu Koga, Hiroki Takashima, Toshirou Nishida, Yasuhiro Matsumura. Mass spectrometry imaging for early discovery and development of cancer drugsAIMS Medical Science 2018; 5(2): 162 doi: 10.3934/medsci.2018.2.162
5
Haonan Li, Runwei Jiao, Jiahui Mu, Shengtao Xu, Xu Li, Xianhua Wang, Zhanlin Li, Jinyi Xu, Huiming Hua, Dahong Li. Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic DerivativesMolecules 2018; 23(11): 2914 doi: 10.3390/molecules23112914
6
Jianwen Zhou, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang, Cuiyan Han. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cellsDrug Delivery 2019; 26(1): 281 doi: 10.1080/10717544.2019.1580799
7
Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano. Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic ApproachesGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7530619
8
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
9
Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, Yuki Homma, Robert M. Hoffman, Itaru Endo. Role of the tumor microenvironment in pancreatic cancerAnnals of Gastroenterological Surgery 2019; 3(2): 130 doi: 10.1002/ags3.12225
10
Ishfaq Ahmed, Sam G. Pappas, Ashiq Masood. Animal Models in Cancer Drug Discovery2019; : 267 doi: 10.1016/B978-0-12-814704-7.00011-8
11
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
12
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert, Nicolai Haertel. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4665-2